Medpace is a drug and biologic contract research organization (CRO) that offers comprehensive services for clinical development, providing integrated solutions through a full-service model.

Medpace

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

COM:MEDPACE

Medpace

Last Close

342.41

14/02 21:00

Market Cap

12.98B

Beta: -

Volume Today

278.41K

Avg: -

Analysis Not Available